LOS ANGELES, CALIF. — NeuroRelief Ketamine & Infusion Therapy, under the medical direction of Dr. Austin Harris, M.D., announces the formal launch of its concierge outpatient program for substance and alcohol abuse recovery. This pioneering program, developed by Dr. Austin Harris, achieves a documented 80% sobriety rate at eight months—starkly contrasting the 10% national average for standard 30-day inpatient programs.
The comprehensive protocol is the only one of its kind globally, integrating advanced ketamine and NAD+ infusions with holistic support and a key technological innovation: the Ascent Sparrow Device. This non-invasive, periauricular device stimulates the vagus nerve to significantly decrease withdrawal symptoms and cravings, particularly for individuals undergoing opiate detox. The program's multi-faceted approach directly addresses the underlying neurological and psychological drivers of addiction, such as trauma, depression, and anxiety.
"The high relapse rates in traditional treatment models indicate a fundamental flaw in how we address addiction," stated Dr. Austin Harris, M.D., Medical Director of NeuroRelief. "Our program moves beyond simple detox. It is designed to repair the brain's reward system and resolve the deep-seated emotional conflicts that fuel substance abuse. The inclusion of the Sparrow Device from day one makes the initial detox phase more manageable, setting a stable foundation for the profound psychological work that follows."
The methodology created by Dr. Austin Harris is rooted in decades of anesthesiology and psychedelic therapy research. It combines medically supervised ketamine infusions—tailored in real time by Dr. Austin Harris, M.D.—with NAD+ for neuro-regeneration, mindfulness-based cognitive training, and dedicated post-infusion integration coaching. This integrated strategy helps patients gently process trauma and rebuild healthy neural patterns without re-traumatization, recovering the brain's innate ability to find reward in daily life.
The program's exceptional outcomes have garnered industry recognition, with NeuroRelief named a Top Addiction Treatment Company for 2024 by Healthcare Business Review.
The clinic's model is built on intensive, personalized care. Each patient receives a detailed initial consultation, and their infusion protocol is continuously adjusted based on their unique physiology and responses. This "whatever it takes" ethos is further supported by concierge-level access to Dr. Austin Harris and his team throughout the treatment process. The program is offered on an outpatient basis, allowing individuals to maintain their daily routines in a familiar environment, which supports long-term habit formation and recovery sustainability.
NeuroRelief is committed to accessibility and offers flexible financing options for all prospective patients, ensuring that credit scores are not a barrier to receiving this advanced care. The launch of this program by Dr. Austin Harris represents a significant shift in addiction treatment, offering a scientifically grounded, compassionate, and highly effective alternative to conventional methods.
About NeuroRelief Ketamine & Infusion Therapy
NeuroRelief Ketamine & Infusion Therapy, located in Sherman Oaks, California, provides advanced, evidence-based infusion treatments for mental health disorders, chronic pain conditions, and substance abuse recovery. Under the leadership of Dr. Austin Harris, the clinic is dedicated to achieving superior patient outcomes through personalized, integrative, and innovative medical protocols.
Contact Info:
Spokesperson: Dr. Austin Harris, M.D.
Organization: NeuroRelief Ketamine & Infusion Therapy
Website: https://neuroreliefketamine.com/
Email: info@neuroreliefketamine.com
© 2025 ScienceTimes.com All rights reserved. Do not reproduce without permission. The window to the world of Science Times.
